Brain-specific tryptophan hydroxylase 2 (TPH2): A functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder

Human Molecular Genetics

Volumn 17, Issue 1, 2008, Pages 87-97

  Cichon, Sven ^a   Winge, Ingeborg ^b   Mattheisen, Manuel ^a   Georgi, Alexander ^c   Karpushova, Anna ^a   Freudenberg, Jan ^d   Freudenberg Hua, Yun ^a   Babadjanova, Gulia ^e   Van den Bogaert, Ann ^f   Abramova, Lilia I ^g   Kapiletti, Sofia ^h   Knappskog, Per M ⁱ   Mckinney, Jeffrey ^b   Maier, Wolfgang ^a   Abou Jamra, Rami ^a   Schulze, Thomas G ^c   Schumacher, Johannes ^a   Propping, Peter ^a   Rietschel, Marcella ^c   Haavik, Jan ^b   Nöthen, Markus M ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BERGEN   (Norway)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^h Moscow Research Institute of Psychiatry   (Russian Federation)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; SERINE; TRYPTOPHAN HYDROXYLASE 2;

5' UNTRANSLATED REGION; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; DNA PRIMERS; ENZYME STABILITY; FEMALE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, SECONDARY; RABBITS; RECOMBINANT PROTEINS; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 37549044251     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm286     Document Type: Article

References (33)

1. Müller-Oerlinghausen, B., Berghofer, A. and Bauer, M. (2002) Bipolar disorder. Lancet, 359, 241-247.
2. Meltzer, H. (1989) Serotonergic dysfunction in depression. Br. J. Psychiatry Suppl., 8, 25-31.
3. Lucki, I. (1998) The spectrum of behaviours influenced by serotonin. Biol. Psychiatry, 44, 151-162.
4. Mann, J.J., Arango, V. and Underwood, M.D. (1990) Serotonin and suicidal behavior. Ann. NY Acad. Sci., 600, 476-484.
5. Placidi, G.P., Oquendo, M.A., Malone, K.M., Huang, Y.Y., Ellis, S.P. and Mann, J.J. (2001) Agressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol. Psychiatry, 50, 783-791.
6. Walther, D.J., Peter, J.U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H. and Bader, M. (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 76.
7. Zill, P., Bahgai, T.C., Zwanzger, P., Schule, C., Eser, D., Rupprecht, R., Möller, H.J., Bondy, B. and Ackenheil, M. (2004) SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry, 9, 1030-1036.
8. Harvey, M., Shink, E., Tremblay, M., Gagne, B., Raymond, C., Labbe, M., Walther, D.J., Bader, M. and Barden, N. (2004) Support for the involvement of TPH2 gene in affective disorder. Mol. Psychiatry, 9, 980-981.
9. Zhang, X., Gainetdinov, R.R., Beaulieu, J.M., Sotnikova, T.D., Burch, L.H., Williams, R.B., Schwartz, D.A., Krishnan, K.R. and Caron, M.G. (2005) Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron, 45, 11-16.
10. Zhou, Z., Roy, A., Lipsky, R., Kuchipudi, K., Zhu, G., Taubman, J., Enoch, M.A., Virkunnen, M. and Goldman, D. (2005) Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydrosyindoleacetic acid in 4 populations. Arch. Gen. Psychiatry, 62, 1109-1118.
11. Van Den Bogaert, A., Sleegers, K., De Zutter, S., Heyrman, L., Norrback, K.-F., Adolfsson, R., Van Broeckhoven, C. and Del-Favero, J. (2006) Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch. Gen. Psychiatry, 63, 1103-1110.
12. Harvey, M., Gagne, B., Labbe, M. and Barden, N. (2007) Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees. Psychiatric Genet., 17, 17-22.
13. Lopez, V.A., Detera-Wadleigh, S., Cardona, I., Kassem, L. and McMahon, F.J. and The National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium (2007) Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol. Psychiatry, 61, 181-186.
14. Zill, P., Büttner, A., Eisenmenger, W., Möller, H.J., Bondy, B. and Ackenheil, M. (2004) Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry, 56, 581-586.
15. DeLuca, V., Mueller, D.J., Tharmalingam, S., King, N. and Kennedy, J.L. (2005) Association study of the novel TPH2 gene in bipolar disorder and suicidality. Mol. Psychiatry, 9, 896-897.
16. Freudenberg-Hua, Y., Freudenberg, J., Kluck, N., Cichon, S., Propping, P. and Nöthen, M.M. (2003) Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population. Genome Res., 13, 2271-2276.
17. Scheuch, K., Lautenschlager, M., Grohmann, M., Stahlberg, S., Kirchheiner, J., Zill, P., Heinz, A., Walther, D.J. and Priller, J. (2007) Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol. Psychiatry, doi:10.1016/j.biopsych.2007.01.015.
18. Wang, L., Erlandsen, H., Haavik, J., Knappskog, P.M. and Stevens, R.C. (2002) Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin. Biochemistry, 22, 12569-12574.
19. Winge, I., McKinney, J.A., Knappskog, P.M. and Haavik, J. (2007) Characterization of WT and mutant forms of human tryptophan hydroxylase 2. J. Neurochem., 100, 1648-1457.
20. McKinney, J.A., Knappskog, P.M. and Haavik, J. (2005) Different properties of the central and peripheral forms of human tryptophan hydroxylase. J. Neurochem., 92, 311-320.
21. Lim, J.E., Pinsonneault, J., Sadee, W. and Saffen, D. (2006) Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol. Psychiatry, 12, 491-501.
22. Kobayashi, K. and Nagatsu, T. (2005) Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem. Biophys. Res. Commun., 338, 267-270.
23. Waters, P.J., Scriver, C.R. and Parniak, M.A. (2001) Homomeric and heteromeric interactions between WT and mutant phenylalanine hydroxylase subunits: Evaluation of two-hybrid approaches for functional analysis of mutations causing hyperphenylalaninemia. Mol. Genet. Metab., 73 230-238.
24. Tenner, K., Walther, D. and Bader, M. (2007) Influence of human tryptopban hydroxylase 2N- and C-terminus on enzymatic activity and oligomerization. J. Neurochem., 102, 1887-1894.
25. Leandro, J., Nascimento, C., de Almeida, I.T. and Leandro, P. (2006) Co-expression of different subunits of human phenylalanine hydroxylase: evidence of negative interallelic complementation. Biochim. Biophys. Acta, 1762, 544-550.
26. Gaspar, P., Cases, O. and Maroteaux, L. (2003) The developmental role of serotonin: News from mouse molecular genetics. Nat. Rev. Neurosci. 4, 1002-1012.
27. Leckman, J.F., Sholomskas, D., Thompson, W.D., Belanger, A. and Weissman, M.M. (1982) Best estimate of lifetime psychiatric diagnosis: A methodological study. Arch. Gen. Psychiatry, 39, 879-883.
28. Spitzer, R.L., Williams, J.B., Gibbon, M. and First, M.B. (1992) The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch. Gen. Psychiatry, 49, 624-629.
29. Farmer, A.E., Wessely, S., Castle, D. and McGuffin, P. (1992) Methodological issues in using a polydiagnostic approach to define psychotic illness. Br. J. Psychiatry, 161, 824-830.
30. Becker, T. and Knapp, M. (2004) Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol, 27 21-32.
31. Dudbridge, F. (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol., 25, 115-121.
32. Cichon, S., Schumacher, J., Muller, D.J., Hürter, M., Windemuth, C., Strauch, K., Hemmer, S., Schulze, T.G., Schmidt-Wolf, G., Albus, M. et al. (2001) A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum. Mol. Genet., 10, 2933-2944.
33. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.